RAC2 and ovarian carcinoma: In ovarian cancer, upregulation of RAC2 is associated with the formation of NETs and poor prognosis of ovarian cancer, and NET‐associated markers are reliable for ovarian cancer prognosis prediction and treatment evaluation [7].